Broad Designations for Treatment of Hemophilia A & B with Inhibitors As Well As Congenital Factor VII Deficiency 10-Year Marketing Exclusivity In Europe Upon Product …
OPKO Announces Positive Interim Six-Month Lagova™ (hGH-CTP) Phase 2 Data in Pediatric Growth Hormone Deficiency Disorder
Interim efficacy results show that a single weekly injection of Lagova (hGH-CTP) can replace seven consecutive daily injections of currently marketed human growth hormone (hGH) …